CardioMech develops devices for structural heart disease, offering alternatives to cardiac surgery, specifically for mitral valve issues.
CardioMech has raised $17.6M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2025.
CardioMech's investors include Hadean Ventures, Investinor, Aerion Partners.
CardioMech is headquartered in Trondheim, Norway.
CardioMech develops devices for structural heart disease, offering alternatives to cardiac surgery, specifically for mitral valve issues.
CardioMech is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CardioMech — Funding & Investors." VCBacked, April 21, 2025, https://www.vcbacked.co/company/cardiomech. Accessed October 2, 2026.
VCBacked. (2025). CardioMech — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/cardiomech
{{cite web |title=CardioMech — Funding & Investors |url=https://www.vcbacked.co/company/cardiomech |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated